EUCTR2016-002120-83-FR进行中（未招募）1 期
Study evaluation of 2nd hormone line response by -[18F]fluoro-17ß-œstradiol (FES) PET/CT in metastatic breast cancer patients
INSTITUT DE CANCEROLOGIE DE L'OUEST RENE GAUDUCHEA0 个研究点开始时间: 2017年1月5日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 30
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 30
排除标准
- 未提供
研究者
相似试验
招募中
2 期
ow grade ovarian cancer treatmentCTRI/2019/08/020566Tata Memorial Centre
已完成
2 期
A Randomized Phase II Study of Maintenance Hormone Therapy with or without Capecitabine after Induction Chemotherapy with Bevacizumab plus Paclitaxel in Hormone Receptor Positive and HER2 Negative Metastatic Breast Cancer (KBCSG-TR1214)Breast cancerJPRN-UMIN000008662KBCSG-TR(Kinki Breast Cancer Study Group-TR)120
招募中
不适用
Comparison between different doses of gonadotropin-releasing hormone agonist used in short stimulation protocol in infertile women undergoing IVFReproductive Health and Childbirth - Fertility including in vitro fertilisationInfertilityACTRN12613000384752Sarhan IVF Cntre90
已完成
不适用
Evaluation blood level of anti-m?llerian hormone measurement efficiency in prediction of the response to weight loss diet in obese women with polycystic ovarian syndrome with infertility problem.Obesity in polycystic ovary syndrome women.Polycystic ovarian syndromeIRCT201302241141N14Royan institute80
已完成
不适用
Evaluating the effect of metformine on antimullerian hormone(AMH ) in polycystic ovarian syndrome –a clinical trialPolycystic ovarian syndrome.IRCT2014081918858N1Diabet Research Center, Yazd Shahid Sadoughi Univercity Of Medical Science42